跳至主要内容
临床试验/CTRI/2025/11/097079
CTRI/2025/11/097079尚未招募不适用

To determine if the dimensions of personality influence the treatment outcomes of yoga and allied therapies

Patanjali Research Foundation Trust1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2025年11月11日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
300
试验地点
1
主要终点
(i) The Big Five Inventory–2

研究概览

简要总结

The objective of the present study is to determine nature of  personality influence the treatment outcomes of a yoga and allied therapies in patients population

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Patients who will be visiting integrated therapy center for their treatment.

排除标准

  • Patients who will return incomplete questionnaires or will not complete 7 days of treatment.

结局指标

主要结局

(i) The Big Five Inventory–2

时间窗: i. The Big Five Inventory will be assessed at baseline (i.e., at day 0) | ii. The EQ-5D-5L will be assessed at baseline (i.e., at day 0) and after seven days of treatment. | iii. Physical Health Questionnaire will be assessed at baseline (i.e., at day 0) and after seven days of treatment. | iv The Global Perceived Effect Scale will be assessed at day 7.

(ii) EQ-5D-5L questionnaire

时间窗: i. The Big Five Inventory will be assessed at baseline (i.e., at day 0) | ii. The EQ-5D-5L will be assessed at baseline (i.e., at day 0) and after seven days of treatment. | iii. Physical Health Questionnaire will be assessed at baseline (i.e., at day 0) and after seven days of treatment. | iv The Global Perceived Effect Scale will be assessed at day 7.

(ii) Physical Health Questionnaire

时间窗: i. The Big Five Inventory will be assessed at baseline (i.e., at day 0) | ii. The EQ-5D-5L will be assessed at baseline (i.e., at day 0) and after seven days of treatment. | iii. Physical Health Questionnaire will be assessed at baseline (i.e., at day 0) and after seven days of treatment. | iv The Global Perceived Effect Scale will be assessed at day 7.

(iii) Global Perceived Effect Scale

时间窗: i. The Big Five Inventory will be assessed at baseline (i.e., at day 0) | ii. The EQ-5D-5L will be assessed at baseline (i.e., at day 0) and after seven days of treatment. | iii. Physical Health Questionnaire will be assessed at baseline (i.e., at day 0) and after seven days of treatment. | iv The Global Perceived Effect Scale will be assessed at day 7.

(iv) The Big Five Inventory–2

时间窗: i. The Big Five Inventory will be assessed at baseline (i.e., at day 0) | ii. The EQ-5D-5L will be assessed at baseline (i.e., at day 0) and after seven days of treatment. | iii. Physical Health Questionnaire will be assessed at baseline (i.e., at day 0) and after seven days of treatment. | iv The Global Perceived Effect Scale will be assessed at day 7.

次要结局

未报告次要终点

研究者

申办方类型
Research institution
责任方
Principal Investigator
主要研究者

Dr Shirley Telles

Patanjali Research Foundation (Trust)

研究点 (1)

Loading locations...

相似试验